Scientists or clinicians with an innovative idea relevant to primary and secondary immunodeficiencies and the role of immunoglobulin therapy are invited to apply. Applications are encouraged from both individuals and teams who may be conducting research at hospitals, universities or independent institutions.


Applicants must meet the following eligibility criteria to apply to the ASPIRE Award program:

  • submit a focused project with goals that can be achieved within 24 months
  • be employed or supported by a hospital, university or independent institution
  • be under the age of 45 at the time point of letter of intent submission

By sending a Letter of Intent, applicants agree to further terms and conditions for applications, outlined below

Applicants authorise Grifols to retain and use their personal information filed for the entire application period. Grifols warrants that all personal information and project proposals will be treated confidentially and will not be disclosed to third parties. For further details please refer to terms and conditions.